Guidelines on Therapeutic Products to Treat Haemophilia and Other Hereditary Coagulation Disorders
Introduction and methods, manufacture of therapeutic coagulation factor concentrates, safety data on which recommendations are based, licensing status, therapeutic guidelines, clinical audit and a review of the guidelines.

Molecular Genetics of Blood Clotting
David Ginsburg, M.D: An article covering von Willebrand Factor, coagulation factor V, plasminogen activator inhibitor-1, primary pulmonary hypertension and bone marrow transplantation.

Protein S Deficiency and Thrombophilia
Information about these rare medical conditions, anticoagulant therapy, research and online forum.

Hypercoagulable States
Thomas G. DeLoughery Associate Professor of Medicine defines this term and does an in depth article.

Medline Plus: Congenital Protein C or S Deficiency
Brief information about these hypercoagulability disorders including causes, treatment, and prognosis.

Viewpoint Online: Coagulation
Features articles about blood coagulation disorders including activated protein C resistance, von Willbrand's disease, and hypercoagulability.

Medline Plus: Factor X Deficiency
Information about this inherited disorder that causes abnormal bleeding including causes, treatment, and prognosis.

Medline Plus: Factor V Deficiency
Provides brief information about this inherited bleeding disorder, which is similar to hemophilia. Includes causes, symptoms, and prognosis.

Medline Plus: Factor VII Deficiency
Brief information about this inherited bleeding disorder including causes, symptoms, and prognosis.

Medline Plus: Factor XII Deficiency
Also known as Hageman factor, this is a congenital coagulation disorder that causes prolonged coagulation in a test tube but does not cause abnormal bleeding. Includes brief information.

UIUC Hematology Resource Page
Features diagrams and information about the various thrombophilic genetic markers, general information about clotting, glossary, and list of research sources.

The Factor VIIa Source
Information about topics related to the pathophysiology, pharmacology, and clinical aspects of bleeding, coagulation, and hemostasis, including information about recombinant coagulation Factor VIIa.

Excessive Blood Clotting
Background, causes, symptoms, and treatment of hypercoagulability.

Evaluation of Recurrent Thrombosis and Hypercoagulability
American Academy of Family Physicians article discussing factors that contribute to excessive clotting.